Keimyung Med J Search

CLOSE


Instructions to authors

  • HOME
  • FOR CONTRIBUTORS
  • Instructions to authors

Table of Contents

General Information

All manuscripts submitted to the Keimyung Medical Journal(KMJ) should conform to the following author’s instructions, and if not specified below, must comply with ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (http://www.icmje.org)’.

Types of Manuscript and Language

The manuscripts submitted to KMJ must be creative and able to contribute to the development of health care, medical services and medical technology, and medical education, including treatment and prevention of diseases. These include original articles, and case reports, review articles (What’s hot?, What’s new?, In-depth review, Clinical practice), editorials. All Manuscripts being submitted must not have been published in other publications, and should not be duplicated in other journals until the end of the review. For the manuscript in the process of review, the author(s) must follow the request of the KMJ editorial board. The language described in the manuscript should be written in Korean or English without mixing, except in special cases, However, all manuscript abstracts should be in English. Academic terms described in the manuscript should use the latest medical terminology published by the Korean Medical Association or the latest terminology in the relevant field.

Research and Publication Ethics

1. Authorship

Author qualifications should be meet the following four conditions. 1) a significant contribution in the concept, design, data collection, analysis and interpretation of the manuscript; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. After the original manuscript is submitted for the first time, the author's change (adding the author, deleting the author, or reordering the author) must be explained to the editor as a letter from the corresponding author, and all authors' signatures must be attached.

  • • Corresponding author and first author: In principle, there should be only one correspondent author per manuscript. KMJ approves when it is clear that the first author made an equal contribution to the corresponding author in conducting the joint research.
  • • Correction of author after publication: KMJ will not revise the author after publication unless it is an obvious editorial mistake.

2. Redundant Publication and Plagiarism

Redundant publication is defined as reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source. Submitted manuscripts must not been published or be under consideration for publication elsewhere and no part of the accepted manuscript should be duplicated in any other journal without the permission of the Editorial Board. If duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal and their institutes will be informed. There will also be penalties for the authors. The plagiarism will be crosscheck through Ithenticate program (https://app.ithenticate.com/) before review.

3. Secondary Publication

Secondary publication may be allowed only with the consent of KMJ editing committee and the journal editing committee that published the original article and in this case, the general requirements of ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org)’ apply.

4. Conflicts of Interest Statement

The corresponding author must inform the editor of any that could influence the author’s interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to specific companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.

5. Rules and Regulations for Human and Animal Research

If the research involves human subjects, it must comply with the ethical standards of the Helsinki Declaration adopted in 1964 and be approved by the Institutional Review Board (IRB). Description materials including photographs should not disclose the patient’s name, initials, and hospital identification number.
For studies involving animal subjects, regulations relating to the breeding and use of laboratory animals should be observed or the ‘NIH Guide for the Care and Use of Laboratory Animals’.

6. Process to Manage Research and Publication Misconduct

In suspected cases of research and publication misconduct, such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflict of interest, ethical issues with a submitted manuscript, appropriation of an author’s idea or data, and complaints against editors, the resolving process will be as per the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The Editorial Board’s decision on the suspected cases will be final.

7. Editorial responsibilities

Editorial board continuously strives to comply with the publishing ethics: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standard; publishing corrections, clarifications, retractions and apologies when needed; no plagiarism, no fraudulent data. Editors are always keeping following responsibilities: responsibility and authority to rejected/accept article; no conflict of interest respect to articles they reject/accept; acceptance of a paper when reasonably certain; promoting publication of correction or retraction when errors are found; preservation of anonymity of reviewers.

Manuscript review process

1. Submission

All manuscripts should be submitted via the e-submission system available at http://e-kmj.org/. Submission of a manuscripts that it has not been published previously and is not under consideration for publication elsewhere. Also, if accepted, the author(s) must agree that the paper will not be published elsewhere in the same form or in any other language, without written consent of the editorial board.

2. Review process

KMJ reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. The next step is to check for plagiarism or duplication through a similarity check, after confirmation that no ethical violations have been detected, it is peer reviewed by at least two anonymous reviewers selected by the editors. The authors’ names and affiliations are removed during the double-blind peer review.

Acceptance of a manuscript is based on the critiques and recommendations of the reviewers. An initial decision will normally be made within three weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by e-mail. If choosing to proceed, the corresponding author must indicate all revisions that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within four weeks of the editorial decision is regarded as a withdrawal. If a revision extension period is required, the author should contact the editorial office.
The editorial board notifies the results of the manuscript's deliberation to the corresponding author in one of the following types: accept, minor revision, major revision or reject.

Copyright, License, Data Sharing

1. Copyright

The copyright for all publications is owned by KMJ and all authors must sign a “Copyright Transfer Agreement” and submit it online through the KMJ electronic submission system. The copyright transfer covers the exclusive right to reproduce and distribute the article, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature.

2. License

KMJ is an Open Access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) that permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Author(s) do not require permission to use any tables or figures published in KMJ in other journals, books, or media for scholarly and educational purposes in accordance with the Budapest Open Access Initiative’s definition of open access.

3. Data Sharing

KMJ accepts the ICMJE Recommendations for data sharing statement policy, unless it is limited to ethics, privacy, or confidentiality issues.

Manuscript Preparation

1. Manuscript Writing

  • 1) The manuscripts can be written in Korean or English, but they cannot be mixed except in special cases. Both Korean and English manuscripts must be accompanied by an English abstract.
  • 2) The manuscript is written MS Word in A4 (21×30 cm) paper at 10 point fonts in double space texts by leaving 2.5cm space in the right, left, top and bottom sides.
  • 3) The manuscripts should be prepared in the following order: cover page, English abstract, main text (introduction, method, result, discussion, summary), references, table and figure descriptions, tables, and figures. Each part starts with a new one.
  • 4) Academic terms should be used based on medical glossaries published by the Korean Medical Association. If there is a translation but it is difficult to convey the meaning, write the original in parentheses after the translation when the translation is used for the first time, After that, only the translations should be described.
    Academic terms, proper nouns, place names, person names, drug names, units, etc. without proper translation may be written directly in the original language.
  • 5) If you must use an abbreviation, use the abbreviation in parentheses after the first term. Only use the abbreviation for future use.
  • 6) Arabic numerals are used for numbers, and metric system for weights and measures. All units should use International Standard (SI) units in principle.

2. Cover page

  • 1) The cover page should include the manuscript type, title, author's name and affiliation, if the manuscript in Korean is written in both Korean and English.
    If there are authors with different affiliations, record the main research institute first, and then write the same shoulder number in the author's name and the affiliation, in the order of the author's name.
  • 2) The title should reflect the intent and content of the manuscript.
    Korean title should not exceed 40 words and English title should not exceed 20 words. The first letter of the English word is capitalized.
  • 3) At the bottom of the cover, write the name, affiliation, address, and contact information of the corresponding author, and related matters such as the grant of research funds and the presentation of the conference.

3. Abstract

  • 1) English abstract should be written without paragraph division and should not exceed 250 words.
  • 2) Keywords can be listed up to 5 at the bottom of the abstract and refer to the Medical Subject Headings (MeSH) provided by the National Library of Medicine.

4. Main text

  • 1) The original articles should be described in the order of introduction, materials and methods (objects and methods), results, discussion, acknowledgment, and conflict of Interest.
  • 2) The case reports should be in the order of introduction, consideration, acknowledgment, and conflict of interests, and the volume of the text should be about 5 pages.

5. References

  • 1) References should be cited in the text and written in English in the order in which they are cited.
  • 2) The author's name should be written with family names and the name should be abbreviated.
  • 3) If there are six or fewer authors, write all author names. If there are more than six authors, write the names of up to six authors and replace them with ‘et al.’.
  • 4) Journal names should use the recognized abbreviation of Index Medicus.
  • 5) References in the main text should be numbered in square brackets in sequential order. Numbers should be written after the author's last name or, if there is no author's last name, before the period or comma in the sentence.
    When there are two or less authors, the author's last name is used. When there are three or more authors, use the first author followed by ‘et al.’
  • 6) References not specified below are described in the general terms of Uniform Requirement for Manuscripts Submitted to Biomedical Journals (2010 edition).

Reference method is based on the following example.

Journal Article:

  • 1. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol 2005;22:51-68.
  • 2. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of america. Clin Infect Dis 2008;46:327-60.
  • 3. Xin H, Liu D, Songyang Z. The telosome/shelterin complex and its functions. Genome Biol. 2008;9. DOI: 10.1186/gb-2008-9-9-232.

Book:

  • 4. Rosai J, Ackerman LV. Rosai and Ackerman's Surgical Pathology. 9th ed. Edinburgh, New York: Mosby; 2004.

Book Section:

  • 5. Zipfel GJ, Day AL. Surgical treatment of intracavernous and paraclinoid internal carotid artery aneurysm. In: Winn HR, editor. Youmans Neurological Surgery. 5th ed. Philadelphia: W.B.Saunders; 2004. p.1895-913.

Web Page:

7. Tables

  • 1) Tables should be arranged in order only those mentioned in the text and numbered Arabic numerals.
  • 2) Tables should be written in English and capitalize only the first letter in the title and legend on the horizontal and vertical axes.
  • 3) The title of the table should appear at the top of the table in the form of a clause or phrase.
  • 4) The table uses only the horizontal solid line of the vertical line, not the vertical line.
  • 5) When referring to a specific table in the text, write ‘Table 1’.
  • 6) When using the abbreviation, explain it at the bottom.

8. Figures

  • 1) The figures are listed and numbered in the order in which they are mentioned in the text.
  • 2) The figures should be clear, with a size of 15 x 20 cm or less, a capacity of 5 MB or less, and a resolution of 300 dpi or more recommended and accept as ppt, jpg, and tif files.
  • 3) In the case of two or more figures of the same number, mark the letters A, B, and C after Arabic numerals.
  • 4) When referring to a specific figure in the text, ‘Fig. 1’ is written.
  • 5) Line drawing should in principle be original. When citing pictures from other papers, in principle, the original author's consent should be obtained.

9. Others

Matters not mentioned in this submission rule are in accordance with general practice.

Author’s Checklist

  • □ The manuscript was not duplicated in the other journal.
  • □ The manuscript was not same content as published in other journals.
  • □ The plaintiff complies with all guidelines for the publication of medical papers.
  • □ The A4 paper had a 2.5cm margin, and the text was 10 points with double space.
  • □ Manuscripts were prepared in the following order: cover page, title, English abstract, introduction, main text, bibliography, Figure description, table, and Figure. Each part started a new page.
  • □ The title is concise but expresses the contents of the text implicitly and clearly.
  • □ English abstract was prepared without paragraph separation, and it did not exceed 250 words.
  • □ The key words did not exceed five, and attached at the bottom of the abstract.
  • □ All references are cited in the text and listed in the order in which they are cited.
  • □ Reference notation matched the submission regulations.
  • □ Titles of tables or figures are in English and displayed consistently.
  • □ Tables or figures were written in a sufficiently understandable manner by themselves and did not list duplicate tables or figures in the text.
  • □ The pictures and photos were produced so clearly that they would not be affected even if they were reduced in print.
  • □ All authors agreed to submit the manuscript.


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
1095 Dalgubeol-daero, Dalseo-gu, Daegu 42601, Korea
Tel: +82-53-258-7585    E-mail: tinlib@dsmc.or.kr                

Copyright © 2021 by Keimyung University School of Medicine.

Developed in M2PI

Close layer
prev next